Hemşirelik Araştırmalarında Randomize Kontrollü Çalışmaların Raporlanması ve Non-farmakolojik CONSORT Uzantısının Kullanımı
Abstract
Keywords
Kanıta dayalı hemşirelik, randomize kontrollü çalışma, hemşirelik araştırması
References
- Akın B, Kocoglu D. (2017). Randomize kontrollü deneyler. Hacettepe Üniversitesi Hemşirelik Fakültesi Dergisi, 4, 1, 73-92.
- Blazeby J, Altman DG, Revicki DA, Moher D, Brundage MD. (2013). Reporting of patient-reported outcomes in randomized trials: The consort pro extension. The Journal of the American Medical Association, 309, 8, 814-822.
- Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P. (2017). Consort statement for randomized trials of nonpharmacologic treatments: A 2017 update and a consort extension for nonpharmacologic trial abstracts. Annals of Internal Medicine, 167, 1, 40-47.
- Boutron I, Guittet L, Estellat C, Moher D, Hrobjartsson A, Ravaud P. (2007). Reporting methods of blinding in randomized trials assessing nonpharmacological treatments. Public Library of Science Medicine, 4, 2, 61.
- Campbell MK, Piaggio G, Elbourne DR, Altman DG; CONSORT Group. (2012). Consort 2010 statement: Extension to cluster randomised trials. British Medical Journal. 345, 5661.
- Chan AW, Altman DG. (2005). Epidemiology and reporting of randomised trials published in pubmed journals. The Lancet, 365, 9465, 1159-1162.
- Cheng CW, Wu TX, Shang HC, Li YP, Altman DG, Moher D, Bian ZX, CONSORT-CHM Formulas 2017 Group (2017). Consort extension for chinese herbal medicine formulas 2017: Recommendations, explanation, and elaboration. Annals of Internal Medicine, 167, 2, 112-121.
- DiCenso A, Guyatt G, Ciliska D. (2005). Evidence-based nursing: A guide to clinical practice. Elsevier Health Sciences, p. 508-509.
- Djulbegovic B, Guyatt GH. (2017). Progress in evidence-based medicine: A quarter century on. The Lancet, 390, 10092, 415- 423.
- Dwan K, Li T, Altman DG, Elbourne D. (2019). Consort 2010 statement: Extension to randomised crossover trials. British Medical Journal, 36, 6, l4378.